ESC 365 - The importance of combination therapy

Open Access

The importance of combination therapy

Session: Cardiovascular risk management of high-risk patients with dyslipidaemia: innovative approaches from assessment to combination therapy

Topic: Drug therapy

Speaker: Professor S. Brouwers (Aalst, BE)

Sponsored by Daiichi Sankyo

Event: ESC Congress 2025

Congress Presentation

Add to my library

About the speaker

Professor Sofie Brouwers

Olv Hospital Aalst, Aalst (Belgium)

15 presentations

6 followers

6 more presentations in this session

Welcome & Introduction

Speaker: Professor K. Ray (London, GB)

Real-world evidence in cardiovascular care: addressing persistent challenges

Speaker: Professor L. Masana (Reus, ES)

Tools and techniques in assessing cardiovascular risk in high-risk patients: latest insights

Speaker: Doctor K. Krychtiuk (Vienna, AT)

Optimising the implementation of oral lipid-lowering therapies in high-risk patients with comorbidities

Speaker: Doctor J. Brandts (Aachen, DE)

Panel discussion: integrating risk assessment and lipid management strategies for effective goal attainment

Speaker: Professor K. Ray (London, GB) Professor L. Masana (Reus, ES) Doctor K. Krychtiuk (Vienna, AT) Professor S. Brouwers (Aalst, BE) Doctor J. Brandts (Aachen, DE)

Access the full session

Cardiovascular risk management of high-risk patients with dyslipidaemia: innovative approaches from assessment to combination therapy

Speakers: Professor S. Brouwers, Professor K. Ray, Professor L. Masana, Doctor K. Krychtiuk, Doctor J. Brandts...

About the event

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress

ESC 365 is supported by

bristol-myers-squibb

Explore sponsored resources

novartis

Explore sponsored resources